Evidence map›Paper›PMID 29967059›Full record

ArticleGenetics2018

Recent Molecular Genetic Explorations of

Victor Ambros, Gary Ruvkun

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Nanotech meets antibiotics: nucleotide antibiotics delivered by lipid nanoparticles.Frontiers in cellular and infection microbiology · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Victor AmbrosProgram in Molecular Medicine; University of Massachusetts Medical School, Worchester, Massachusetts 01605 victor.ambros@umassmed.edu.
Gary RuvkunDepartment of Genetics, Harvard University, Boston, Massachusetts.
Massachusetts General Hospital · US

Funding

CONTROL OF THE C ELEGANS LINEAGE BY HETEROCHRONIC GENESR01GM044619 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI GARY B RUVKUN · 1991 to 2026
$14.5M
GENETIC CONTROL OF NEMATODE DEVELOPMENTR01GM034028 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI AMBROS, VICTOR · 1985 to 2018
$7.0M
Genetic control of developmental timingR35GM131741 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Victor Ambros · 2019 to 2026
$5.9M
microRNA gene networks regulating responses to environmentR01GM104904 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI AMBROS, VICTOR · 2014 to 2017
$2.5M
NIGMS NIH HHS R01 GM034028NIGMS NIH HHS R01 GM044619NIGMS NIH HHS R01 GM104904NIGMS NIH HHS R35 GM131741
6 · The paper itself

Abstract

MicroRNAs are small, noncoding RNAs that regulate gene expression at the post-transcriptional level in essentially all aspects of

Indexed as

Gene Regulatory NetworksAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsComputer SimulationGene Expression Regulation, DevelopmentalMicroRNAsMutationPhylogenyCaenorhabditis elegans ProteinsMicroRNAsArgonauteCaenorhabditis elegansmicroRNAmiRISCmutant phenotypesWormBook

Identifiers

PMID29967059
PMCPMC6028246
OpenAlexW2809770898

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.